Search Within

Kara Long Roche

Formats
  1. Journal Article (128)
  2. Meeting Abstract (107)
  3. Review (6)
  4. Editorial (5)
  5. Book Section (3)
  6. Correspondence (3)
  7. Miscellaneous (1)
  8. Research Letter (1)
Groups
  1. GDMT, Surgery (254)
  2. Gynecology Disease Management Team (254)
  3. Surgery (254)
  4. Survivorship Research (168)
  5. Graduate Medical Education (135)
  6. GME, Surgery (132)

More Groups

People
  1. Dennis Chi (182)
  2. Yukio Sonoda (150)
  3. Ginger Gardner (143)
  4. Nadeem Abu-Rustum (138)
  5. Oliver Zivanovic (129)
  6. Mario Leitao (78)

More People

Years
  1. 2025 (12)
  2. 2024 (39)
  3. 2023 (34)
  4. 2022 (30)
  5. 2021 (24)
  6. 2020 (35)

More Years

Publications
  1. Gynecologic Oncology (133)
  2. International Journal of Gynecological Cancer (40)
  3. Journal of Clinical Oncology (13)
  4. Gynecologic Oncology Reports (6)
  5. Annals of Surgical Oncology (4)
  6. American Journal of Obstetrics and Gynecology (3)

More Publications

Publishers
  1. Elsevier B.V. (138)
  2. Lippincott Williams & Wilkins (46)
  3. American Society of Clinical Oncology (20)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (7)
  6. Wiley Blackwell (6)

More Publishers

Results (254)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Salpingectomy for the risk reduction of ovarian cancer: Is it time for a salpingectomy-alone approach?
    Journal Article

    Boerner, T.; Long Roche, K.
    Journal of Minimally Invasive Gynecology (2021)

    Fulltext@MSK | Save
  • Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary study
    Journal Article

    Boerner, T.; Walch, H. S.; Nguyen, B.; Iasonos, A.; Zhou, Q. C.; Schultz, N.; Chui, M. H.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
    Journal Article

    Oseledchyk, A.; Gemignani, M. L.; Zhou, Q. C.; Iasonos, A.; Elahjji, R.; Adamou, Z.; Feit, N.; Goldfarb, S. B.; Long Roche, K.; Sonoda, Y.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events
    Journal Article

    Straubhar, A. M.; Wolf, J. L.; Zhou, Q. C.; Iasonos, A.; Cham, S.; Wright, J. D.; Long Roche, K.; Chi, D. S.; Zivanovic, O.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Attitudes towards risk-reducing salpingectomy: Listen to the patients
    Editorial

    Long Roche, K.
    BJOG: An International Journal of Obstetrics and Gynaecology (2021)

    Fulltext@MSK | Save
  • Prophylactic negative pressure wound therapy after laparotomy for gynecologic surgery: A randomized controlled trial
    Journal Article

    Leitao, M. M. Jr.; Zhou, Q. C.; Schiavone, M. B.; Cowan, R. A.; Smith, E. S.; Iasonos, A.; Veith, M.; Rafizadeh, M.; Curran, K.; Ramesh, B.; more...
    Obstetrics and Gynecology (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Boerner, T.; Tanner, E.; Filippova, O.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; O'Cearbhaill, R. E.; Grisham, R. N.; Gardner, G. J.; Sonoda, Y.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: What is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; O'Cearbhaill, R.; Konner, J. A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save